Skip to content

Arvinas ARVN Increase (Decrease) in Prepaid Expense and Other Assets

Increase (Decrease) in Prepaid Expense and Other Assets at other companies

Nurix Therapeutics, Inc. logo
Nurix Therapeutics, Inc.NRIX
-$1.29M-121%
Kymera Therapeutics logo
Kymera TherapeuticsKYMR
$3.57M+228%
Monte Rosa Therapeutics, Inc. logo
Monte Rosa Therapeutics, Inc.GLUE
$2.92M+72,925%
ArriVent BioPharma, Inc. logo
ArriVent BioPharma, Inc.AVBP
$2.56M+61.0%
Immunome logo
ImmunomeIMNM
$5.1M+199%
Olema Pharmaceuticals, Inc. logo
Olema Pharmaceuticals, Inc.OLMA
-$2.6M-373%

Other financials

Income statement

See full
Revenue$15.6M-91.7%
Operating income-$63.8M-189%
Net income-$57.6M-169%
EPS (diluted)-$0.90-179%

Balance sheet

See full
Cash & equivalents$87.3M+7.8%
Total debt$8.6M-19.6%
Total equity$386.8M-41.4%
Total assets$647.5M-35.3%

Cash flow

See full
Operating cash flow-$69.2M+22.2%
CapEx$1.3M+225%
Free cash flow-$70.5M+21.1%

Valuation

See full
Market cap$518.11M-4.6%
Enterprise value$439.41M-7.1%
P/S5.8×+4.5×

Profitability

See full
Operating margin-283.8%-310pp
Net margin-247.5%-260pp
FCF margin-287.4%

Returns & leverage

See full
Return on equity-42.3%-53.5pp
Debt / equity0.0×
Current ratio5.4×+0.9×

Where this comes from

Reported directly by Arvinas in its filing.

Tagged under the XBRL concept us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets.

The official record: Arvinas’s 10-Q, filed May 11, 2026, on SEC EDGAR. View the filing →

Ask your AI about Arvinas's increase (decrease) in prepaid expense and other assets.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Arvinas's increase (decrease) in prepaid expense and other assets?
Arvinas (ARVN) reported increase (decrease) in prepaid expense and other assets of $600K in Q1 2026.
How has Arvinas's increase (decrease) in prepaid expense and other assets changed year-over-year?
Arvinas's increase (decrease) in prepaid expense and other assets decreased by 77.8% year-over-year, from $2.7M to $600K.
What is the long-term trend for Arvinas's increase (decrease) in prepaid expense and other assets?
Over 3 years (2021 to 2025), Arvinas's increase (decrease) in prepaid expense and other assets has grown at a -27.0% compound annual growth rate (CAGR), from $13.6M to -$5.3M.
What does increase (decrease) in prepaid expense and other assets mean?
This tracks changes in cash paid in advance for goods or services that will be consumed in future periods. It reflects the timing difference between cash outflows and the recognition of related expenses on the income statement.